QIAGEN powered by

Exploring bevacizumab response in low-grade glioma – Oct. 11

Date: 2022/10/11 Duration: 01:30:00 Presented by:

In this training, we’ll help you navigate the interesting intersection of the tumor microenvironment, mutation status and gene expression to identify plausible activators affecting bevacizumab targets in low-grade glioma (LGG).

During this training, you will learn about:
• The tools used to identify key genes in LGG
• How to choose specific gene alterations
• The intersection between immune response tumor mutations
• How to identify other key genes of interest
• How to build a network tying all these elements together